# Tacrolimus to Sirolimus Conversion for Delayed Graft Function

> **NCT00931255** · PHASE4 · TERMINATED · sponsor: **University of Maryland, Baltimore** · enrollment: 32 (actual)

## Conditions studied

- Kidney Transplant
- Delayed Graft Function

## Interventions

- **DRUG:** Tacrolimus
- **DRUG:** Sirolimus

## Key facts

- **NCT ID:** NCT00931255
- **Lead sponsor:** University of Maryland, Baltimore
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-04
- **Primary completion:** 2014-06
- **Final completion:** 2014-07
- **Target enrollment:** 32 (ACTUAL)
- **Why stopped:** The trial was stopped because of slow recruitment.
- **Last updated:** 2022-03-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00931255

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00931255, "Tacrolimus to Sirolimus Conversion for Delayed Graft Function". Retrieved via AI Analytics 2026-08-01 from https://api.ai-analytics.org/clinical/NCT00931255. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*